Targeting insulin ‐like growth factor 2 mRNA‐binding protein 1 (IGF2BP1) in metastatic melanoma to increase efficacy of BRAFV600E inhibitors

This article is protected by copyright. All rights reserved

Source: Molecular Carcinogenesis - January 25, 2018 Category: Molecular Biology Authors: Tae Won Kim, Thomas Havighurst, KyungMann Kim, Mark Albertini, Yaohui G. Xu, Vladimir S. Spiegelman Tags: Brief Communication Source Type: research